Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Net Margin (2016 - 2026)

Mimedx's Net Margin history spans 15 years, with the latest figure at 18.41% for Q1 2026.

  • On a quarterly basis, Net Margin changed N/A to 18.41% in Q1 2026 year-over-year; TTM through Mar 2026 was 2.79%, a 1214.0% decrease, with the full-year FY2025 number at 11.6%, down 43.0% from a year prior.
  • Net Margin hit 18.41% in Q1 2026 for Mimedx, down from 8.01% in the prior quarter.
  • Over the last five years, Net Margin for MDXG hit a ceiling of 51.63% in Q4 2023 and a floor of 20.5% in Q1 2022.
  • Historically, Net Margin has averaged 3.94% across 4 years, with a median of 8.65% in 2023.
  • Biggest five-year swings in Net Margin: soared 4069bps in 2023 and later tumbled -4362bps in 2024.
  • Tracing MDXG's Net Margin over 4 years: stood at 10.94% in 2022, then surged by 372bps to 51.63% in 2023, then tumbled by -84bps to 8.01% in 2024, then tumbled by -330bps to 18.41% in 2026.
  • Business Quant data shows Net Margin for MDXG at 18.41% in Q1 2026, 8.01% in Q4 2024, and 9.37% in Q3 2024.